Part of the Menarini Group, Lusochimica aims to create a greener, more efficient synthesis of nebivolol, a widely used cardiovascular drug. The project will immobilise two alcohol dehydrogenase enzymes on solid support and integrate them into flow chemistry, optimising conditions at the laboratory and pilot scale. By establishing a European-based, competitive production, this initiative enhances sustainability, scalability, and pharmaceutical sovereignty.
- Beneficiaries
Coordinators: Lusochimica
- Project Locations
Italy
- EU funding
€1.7 million
- Funding sources
Explore EU innovative projects awarded the STEP Seal. View projects’ details, funding status, and connect with promoters via the interactive dashboard.
Other STEP stories on digital tech
Axelera-FAST (Fueling Axelera’s Semiconductor & AI Transformation) is a project designed to scale Axelera AI up and mass-produce Europe’s first fully sovereign AI acceleration platform.
Europe’s critical infrastructure needs smarter protection. MIRAGE brings together autonomous robots, advanced sensors and AI to monitor energy sites and logistics hubs with greater precision, wider coverage and lower cost.
OpenEuroLLM will develop a family of Large Language Model (LLMs) covering all EU official languages, ensuring transparency, compliance with the AI Act, and uptake among European businesses, startups, and innovators